Amri, P. (2021). Which Complication is More Important in the Treatment of Patients with COVID-19? Rhabdomyolysis or Myocardial Injury. TANAFFOS (Respiration), 20(1), 5–6.
MLA
Amri, P. "Which Complication is More Important in the Treatment of Patients with COVID-19? Rhabdomyolysis or Myocardial Injury", TANAFFOS (Respiration), 20, 1, 2021, 5–6.
HARVARD
Amri, P. (2021). 'Which Complication is More Important in the Treatment of Patients with COVID-19? Rhabdomyolysis or Myocardial Injury', TANAFFOS (Respiration), 20(1), pp. 5–6.
CHICAGO
Amri, P., "Which Complication is More Important in the Treatment of Patients with COVID-19? Rhabdomyolysis or Myocardial Injury." TANAFFOS (Respiration), 20 1 (2021): 5–6,
VANCOUVER
Amri P. Which Complication is More Important in the Treatment of Patients with COVID-19? Rhabdomyolysis or Myocardial Injury. TANAFFOS (Respiration). 2021;20(1):5–6.
